Abigail Clarkson-During, Ellen Almirol, Dylan Eller, Aniruddha Hazra, Kimberly A Stanford
{"title":"Risk factors for treatment non-completion among patients with syphilis.","authors":"Abigail Clarkson-During, Ellen Almirol, Dylan Eller, Aniruddha Hazra, Kimberly A Stanford","doi":"10.1177/20499361241265941","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>With recent increases in syphilis, there is growing interest in expanding screening; however, treatment rates have historically been low.</p><p><strong>Objectives: </strong>This study examines demographic and clinical factors that may contribute to non-completion of syphilis treatment.</p><p><strong>Design: </strong>This is a retrospective comparative cohort study of all patients with syphilis from January through November 2018 at an urban, tertiary care hospital.</p><p><strong>Methods: </strong>Demographics and clinical information were extracted from the electronic medical record. Descriptive statistics and odds ratios (ORs) were calculated.</p><p><strong>Results: </strong>Of 171 patients with syphilis, 89 (52.0%) completed treatment. Patients ages 40-49 were least likely to complete treatment (OR 0.14; 95% CI 0.03-0.72, <i>p</i> = 0.02) compared to those ages 18-24. Non-heterosexual patients were significantly more likely to complete treatment (OR 3.60; 95% CI 1.13-11.49, <i>p</i> = 0.03) compared to heterosexual patients. Patients diagnosed in the emergency department completed treatment at the lowest rate.</p><p><strong>Conclusion: </strong>A major gap in syphilis treatment still exists, which must be addressed to achieve optimal impact from syphilis screening programs.</p>","PeriodicalId":46154,"journal":{"name":"Therapeutic Advances in Infectious Disease","volume":"11 ","pages":"20499361241265941"},"PeriodicalIF":3.8000,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292680/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Infectious Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20499361241265941","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: With recent increases in syphilis, there is growing interest in expanding screening; however, treatment rates have historically been low.
Objectives: This study examines demographic and clinical factors that may contribute to non-completion of syphilis treatment.
Design: This is a retrospective comparative cohort study of all patients with syphilis from January through November 2018 at an urban, tertiary care hospital.
Methods: Demographics and clinical information were extracted from the electronic medical record. Descriptive statistics and odds ratios (ORs) were calculated.
Results: Of 171 patients with syphilis, 89 (52.0%) completed treatment. Patients ages 40-49 were least likely to complete treatment (OR 0.14; 95% CI 0.03-0.72, p = 0.02) compared to those ages 18-24. Non-heterosexual patients were significantly more likely to complete treatment (OR 3.60; 95% CI 1.13-11.49, p = 0.03) compared to heterosexual patients. Patients diagnosed in the emergency department completed treatment at the lowest rate.
Conclusion: A major gap in syphilis treatment still exists, which must be addressed to achieve optimal impact from syphilis screening programs.
背景:随着近来梅毒发病率的上升,人们对扩大筛查范围的兴趣日益浓厚;然而,治疗率历来较低:本研究探讨了可能导致未完成梅毒治疗的人口统计学和临床因素:这是一项回顾性比较队列研究,研究对象为一家城市三级甲等医院2018年1月至11月的所有梅毒患者:从电子病历中提取人口统计学和临床信息。结果:在171名梅毒患者中,梅毒的发病率为1.5%:在171名梅毒患者中,89人(52.0%)完成了治疗。与18-24岁的患者相比,40-49岁的患者完成治疗的可能性最小(OR 0.14; 95% CI 0.03-0.72, p = 0.02)。与异性恋患者相比,非异性恋患者完成治疗的可能性明显更高(OR 3.60; 95% CI 1.13-11.49, p = 0.03)。在急诊科确诊的患者完成治疗的比例最低:梅毒治疗仍存在很大差距,必须加以解决,才能使梅毒筛查项目取得最佳效果。